AU2369801A - Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation - Google Patents

Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation

Info

Publication number
AU2369801A
AU2369801A AU23698/01A AU2369801A AU2369801A AU 2369801 A AU2369801 A AU 2369801A AU 23698/01 A AU23698/01 A AU 23698/01A AU 2369801 A AU2369801 A AU 2369801A AU 2369801 A AU2369801 A AU 2369801A
Authority
AU
Australia
Prior art keywords
additive
pharmaceutical composition
transdermally administering
enhances permeation
administering hormones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23698/01A
Inventor
Achim Berthold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of AU2369801A publication Critical patent/AU2369801A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU23698/01A 2000-01-07 2000-12-23 Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation Abandoned AU2369801A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10000333 2000-01-07
DE2000100333 DE10000333A1 (en) 2000-01-07 2000-01-07 Pharmaceutical composition for the transdermal administration of hormones with a permeation-improving additive
PCT/EP2000/013268 WO2001049273A2 (en) 2000-01-07 2000-12-23 Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation

Publications (1)

Publication Number Publication Date
AU2369801A true AU2369801A (en) 2001-07-16

Family

ID=7626866

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23698/01A Abandoned AU2369801A (en) 2000-01-07 2000-12-23 Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation

Country Status (4)

Country Link
AR (1) AR026797A1 (en)
AU (1) AU2369801A (en)
DE (1) DE10000333A1 (en)
WO (1) WO2001049273A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2873371B1 (en) * 2004-07-26 2008-07-04 Sod Conseils Rech Applic NEW METHOD OF SYNTHESIS OF 2,5 DIOXANE 1,4 DIONES
DE102006050558B4 (en) 2006-10-26 2009-03-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing norelgestromin for contraception and hormone replacement
DE102010004769A1 (en) 2009-07-08 2011-01-13 Kuchenbecker, Manfred, Dr.-Ing. Reluctance generator for feed in alternating or three-phase current constant voltage and constant frequency at variable speed, is provided with multiple uniform oppositely displaced partial phases for phase of output voltage
RS57845B1 (en) 2012-02-09 2018-12-31 Novus Int Inc Heteroatom containing cyclic dimers
BR112015000494A2 (en) 2012-07-12 2017-06-27 Novus Int Inc matrix and layer compositions for the protection of biotives
CN105579024A (en) 2013-08-09 2016-05-11 得凯莫斯公司弗罗里达有限公司 Skin care compositions having cyclic diesters and methods thereof
US10584306B2 (en) 2017-08-11 2020-03-10 Board Of Regents Of The University Of Oklahoma Surfactant microemulsions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002079B (en) * 1994-07-26 1995-12-05 Lavipharm A E System of a special structure and composition for the rapid transdermal administration of oestrogens.
AU6032696A (en) * 1995-06-07 1996-12-30 Cygnus Therapeutic Systems Pressure sensitive acrylate adhesive composition cross-linke d with aluminum acetylacetonate and containing a drug having a reactive aromatic hydroxyl group

Also Published As

Publication number Publication date
WO2001049273A2 (en) 2001-07-12
AR026797A1 (en) 2003-02-26
DE10000333A1 (en) 2001-07-19
WO2001049273A3 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
AU7361400A (en) Prodrugs for liver specific drug delivery
HUP0204372A3 (en) Pharmaceutical compositions providing enhanced drug concentrations
AU7912100A (en) Pharmaceutical composition comprising an antigen
AU2001235009A1 (en) Drug delivery apparatus
DK0938316T3 (en) Opioid antagonist-containing galenic formulation
AU2001258242A1 (en) Dose display for injection device
WO2005065318A3 (en) Effervescent oral opiate dosage form
AU2002236647A1 (en) Method and device for administering medication and/or placebo
AU2003289440A1 (en) Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof
ZA200410211B (en) Quinuclidine derivatives and pharmaceutical compositions containing the same.
AU2001232020A1 (en) Floating drug delivery composition
ATE287264T1 (en) ORAL MEDICINAL PRODUCTS CONTAINING BUPRENORPHINE
AU2001244713A1 (en) Transporters and drug delivery system by using the same
AU2001272293A1 (en) Device for administering an injectable product
AU2001290239A1 (en) Medicinal composition
AU2001276831A1 (en) Delivery vehicle composition and methods for delivering antigens and other drugs
WO2002011724A3 (en) Neuroprotective 2-pyridinamine compositions and related methods
AU2000272858A1 (en) Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments
AU2369801A (en) Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation
AU2001224818A1 (en) Device for administering liquids
AU2001258443A1 (en) Drug delivery device, especially for the delivery of gestodene
AU2002222750A1 (en) Pharmaceutical composition for intramuscular injection containing loxoprofen
AU5072000A (en) Pharmaceutical composition for nasally administering water-soluble active substances
AU2001258442A1 (en) Drug delivery device, especially for the delivery of levonorgestrel
AU4085201A (en) Pharmaceutical composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase